Fibrosis-4 Model Influences Results of Patients with Hepatocellular Carcinoma Undergoing Hepatectomy

Figure 2

The 1-year, 3-year, and 5-year overall survival between fibrosis-4 ≥3.15 group and fibrosis-4<3.15 group. Fibrosis-4 ≥3.15 group had worse survival than the fibrosis-4<3.15 group, with the corresponding 1-year, 3-year, and 5-year overall survival of 80.9%, 56.3%, and 44.6% for fibrosis-4 ≥3.15 group and 86.5%, 69.9%, and 63.2% for fibrosis-4<3.15 group (P<0.001).